US Stocks
/
Fulcrum Therapeutics, Inc. Share Price
Fulcrum Therapeutics, Inc. Share Price

Fulcrum Therapeutics, Inc. Share Price

NASDAQ: FULC | Micro Cap
$3.69
-$0.02 (-0.4%) Last updated on 08 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Fulcrum Therapeutics, Inc. Stock Performance

Open
$3.71
Prev. Close
$3.71
Circuit Range
N/A
Day Range
$3.68 - $3.71
Year Range
$2.92 - $15.46
Volume
71,093
Average Traded
$3.69

Fulcrum Therapeutics, Inc. Share Price Today

As of 8 October 2026, Fulcrum Therapeutics, Inc.'s share price is $3.69. The stock opened at $3.71, compared to its previous close of $3.71. During today's trading session, Fulcrum Therapeutics, Inc.'s share price traded between $3.68 and $3.71, with an average price of $3.70. Over the past 52 weeks, the stock has recorded a high of $15.46 and a low of $2.92. In terms of performance, Fulcrum Therapeutics, Inc.'s share price has declined by 48.17% over the last six months and is down 57.73% on a year-on-year basis.

Fulcrum Therapeutics, Inc. Share Price Chart

$3.68$3.71
L
Show Current Price
H

Fulcrum Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$233779.95
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.11
Revenue (TTM)
$0.00
Return On Equity (TTM)
-27.36%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-33.57%

Fulcrum Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$19.60-$20.33-$18.89-$26.18
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-3.72%7.08%-38.59%

Fulcrum Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$6.34$2.81$80.00$0.00
Net Profit-$109.87-$97.34-$9.73-$74.88
Net Profit Margin-1732.97%-3464.06%-12.16%N/A
Income ChangeN/A11.40%90.00%-669.58%

About Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

Fulcrum Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$3.70
$3.69
-0.27%
Sep 2026
$3.86
$3.69
-4.03%
Aug 2026
$3.62
$3.85
+7.54%
Jul 2026
$3.66
$3.58
-1.92%
Jun 2026
$6.77
$3.65
-47.33%
May 2026
$7.09
$6.93
-2.67%
Apr 2026
$7.88
$7.12
-7.23%
Mar 2026
$8.26
$7.67
-8.52%
Feb 2026
$11.01
$8.39
-21.88%
Jan 2026
$11.37
$10.74
-5.08%
Dec 2025
$10.84
$11.31
+3.24%
Nov 2025
$8.71
$10.96
+25.54%

FULC Share Price FAQs

What is Fulcrum Therapeutics, Inc. share price today?

chevron-up
Fulcrum Therapeutics, Inc. share price today is $3.69 as on October 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Fulcrum Therapeutics, Inc. stock?

chevron-up
The 52 week high of Fulcrum Therapeutics, Inc. stock is $15.46, while the 52 week low is $2.92 as of 8 Oct '26.

What is FULC's market capitalisation today?

chevron-up
FULC market capitalisation is $233779.95 as of October 8, 2026, at 4:09 pm IST.

What is FULC's net income for the last quarter?

chevron-up
FULC's net income for the last quarter is -26.18B USD.

What is the 5 year returns of FULC?

chevron-up
The 5 year returns of FULC is -83.33% as on 8 Oct '26.

What is the high & low stock price of FULC today?

chevron-up
FULC stock price hit a high of $3.71 and low of $3.68 as of 8 Oct '26.

Can I buy FULC shares in India?

chevron-up
Yes. You can buy FULC in India by opening an international trading account.